Seeking Alpha

CVS Health Corporation (CVS)

  • Mar. 28, 2013, 9:18 AM
    Look for a new report from Consumer Reports on the cost of prescription drugs at retail chains to create some buzz. Analysis by the publication shows that consumers can save as much as $100 a month by comparison shopping. Costco (COST) came in the low end of the scale for generic drug prices while CVS Caremark (CVS) was the highest. Drugstore chains (WAG, RAD) could face increasing pricing pressure with big box retailers more willing to use low prices at their pharmacies as a traffic driver.
  • Mar. 6, 2013, 3:47 PM
    CVS Caremark Corporation (CVS) declares $0.225/share quarterly dividend, in line with previous. Forward yield 1.72%. For shareholders of record Apr. 23. Payable May 03. Ex-div date Apr. 19. (PR)
    | Comment!
  • Mar. 1, 2013, 7:14 AM
    Drugstore chains (WAG, CVS, RAD) continue to push further into healthcare to make up for lagging prescription drug sales. The latest development is an initiative by Rite Aid to open 58 stores which have in-store clinics where customers can interact with a doctor using a Web cam. Customers in Baltimore, Boston, Philadelphia, and Pittsburgh can pay $45 for a 10-minute consult with a doctor via a PC.
  • Feb. 19, 2013, 12:37 PM
    CVS Caremark (CVS +2.6%) and Rite Aid (RAD +5.4%) both trade higher, riding the back of a strong quarter and promising guidance from Express Scripts. Sector peer Walgreen (WAG +0.9%) isn't quite keeping up despite a price target boost by Cantor Fitzgerald to $45.
  • Feb. 11, 2013, 2:21 PM
    After seeing the number of flu shots administered skyrocket this year to boost revenue, drug store operators such as Walgreen (WAG +0.1%) and CVS Caremark (CVS +0.1%) want to expand past flu shots to offer a full range of immunizations and additional healthcare services. For the sector to gets its way, states will have to expand the powers of pharmacists, a development that stands a decent chance of coming off because it saves employers money.
    | 1 Comment
  • Feb. 6, 2013, 7:18 AM
    More on CVS Caremark's (CVS) Q4: Revenue in the Retail Pharmacy segment rose 5.1% to $16.3B as higher traffic more than offset the impact of new generic introductions. An effective tax rate and share count that were lower than anticipated contributed to the EPS beat. The company sees FY13 EPS of $3.86-$4.00, roughly in-line with the consensus estimate of analysts calling for $3.94. (PR)
    | Comment!
  • Feb. 6, 2013, 7:01 AM
    CVS Caremark (CVS): Q4 EPS of $1.14 beats by $0.03. Revenue of $31.4B (+10.9% Y/Y) beats by $0.27B. (PR)
    | Comment!
  • Feb. 6, 2013, 12:05 AM
    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED
    | Comment!
  • Feb. 5, 2013, 5:30 PM
    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED
    | Comment!
  • Jan. 30, 2013, 10:48 AM
    CVS Caremark (CVS +0.6%) continues to draw attention from investment managers as it retains more customers added on during the Express Scripts-Walgreen dispute than anticipated and sees increased traffic into its stores due to the national flu epidemic. Despite a 7% YTD run already, share could move even higher if Q4 numbers come in strong.
    | Comment!
  • Jan. 18, 2013, 12:27 PM
    The latest report from the CDC on the national outbreak of the flu shows nine more children deaths to bring the season's total to 29. Doctor visits are still on the rise as is demand for flu shots at drugstore chains CVS Caremark (CVS -0.4%), Rite Aid (RAD +1.3%), and Walgreen (WAG -0.3%).
  • Jan. 14, 2013, 9:04 AM
    Reports on major drugstore chains running out of flu shots over the weekend tip off that Walgreen (WAG), Rite Aid (RAD), and CVS Caremark (CVS) may be seeing increased traffic due to the national outbreak of the flu. Typically, the chains pick up some incremental grocery sales during a heightened flu season.
    | 1 Comment
  • Jan. 7, 2013, 7:31 PM
    The SEC is looking in to a report that Washington Council Ernst & Young violated auditor rules by letting its lobbying unit perform work for several major audit clients including Amgen (AMGN), CVS Caremark (CVS) and Verizon (VZ). U.S. independence rules bar auditors from serving in an "advocacy role" for audit clients, but it's unclear how far along the probe is, or whether it will result in any civil charges.
    | Comment!
  • Jan. 7, 2013, 11:24 AM
    The early start to the flu season is expected to bring in more traffic to pharmacy chains Walgreen (WAG +2.2%), CVS Caremark (CVS -1.1%) and Rite Aid (RAD -2.6%) as the national media picks up on the story. The CDC reports 41 states have "widespread influenza" activity and says 52.6% of patients visit are for flu illnesses - compared to a national baseline average of around 2.2%.
    | Comment!
  • Dec. 20, 2012, 9:17 AM
    Shares of Walgreen (WAG) and CVS Caremark (CVS) are on watch after Rite Aid reported its first quarterly profit since 2007. The quick analyst take on the drugstore chain shakeup is that Rite Aid's execution is behind the strong Q3 more than sector strength.
    | Comment!
  • Dec. 14, 2012, 10:04 AM
    Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to grow based on its "distinctive positioning" in the sector. Despite all the sound and fury from Walgreen (WAG -0.1%) on recapturing its lost customers back, the opposite appears to be the reality as the CVS share in the prescription market rises instead of falls.
    | Comment!
Visit Seeking Alpha's
CVS vs. ETF Alternatives
Company Description
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Healthcare
Industry: Drug Stores
Country: United States